ARDX
VENTE TOTALE: 100 242 titres (~436 837,48 $ US)
- Insiders
- RAAB MICHAEL
- Total bought
- —
- Total sold
- $436,837
- Last activity
- 2026-08-21
- Last synced
-
2026-08-27 10:00:12
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Bearish signal Scored 2026-08-27
ARDX presents a deeply unfavorable risk profile: a weak catalyst score of 10 driven by a guidance cut, an 18% stock collapse, and active securities investigations leave no credible near-term upside catalyst.
The first sentence of the analysis written for ARDX on 2026-08-27 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 89.5% | 84.8% | 85.7% | 92.1% | 90.1% | |
| Ebit Margin | -7.9% | -5.6% | -45.5% | -119.1% | -1521.8% | |
| Ebitda Margin | -7.2% | -5.0% | -44.5% | -116.9% | -1494.0% | |
| Operating Profit Margin | -10.1% | -8.4% | -50.8% | -122.2% | -1528.6% | |
| Pretax Profit Margin | -14.9% | -11.7% | -52.6% | -128.8% | -1566.4% | |
| Continuous Operations Profit Margin | -15.1% | -11.7% | -53.1% | -128.9% | -1566.5% | |
| Net Profit Margin | -15.1% | -11.7% | -53.1% | -128.9% | -1566.5% | |
| Bottom Line Profit Margin | -15.1% | -11.7% | -53.1% | -128.9% | -1566.5% | |
| Current Ratio | 4.315 | 4.580 | 4.884 | 2.341 | 2.530 | |
| Quick Ratio | 4.115 | 4.308 | 4.637 | 2.291 | 2.530 | |
| Solvency Ratio | -0.175 | -0.141 | -0.495 | -0.720 | -2.309 | |
| Cash Ratio | 0.767 | 0.834 | 0.426 | 1.465 | 1.371 | |
| Price To Earnings Ratio | -22.423 | -29.824 | -20.667 | -6.786 | -0.724 | |
| Price To Earnings Growth Ratio | -0.424 | 0.688 | 0.723 | 0.094 | -0.016 | |
| Forward Price To Earnings Growth Ratio | -0.424 | 0.688 | 0.723 | 0.094 | -0.016 | |
| Price To Earnings Diluted Ratio | -22.423 | -29.824 | -20.667 | -6.786 | -0.724 | |
| Price To Earnings Diluted Growth Ratio | -0.424 | 0.688 | 0.723 | 0.094 | -0.016 | |
| Price To Book Ratio | 8.417 | 6.882 | 8.152 | 4.600 | 1.387 | |
| Price To Sales Ratio | 3.450 | 3.575 | 10.926 | 8.671 | 11.353 | |
| Price To Free Cash Flow Ratio | -31.955 | -26.029 | -15.099 | -6.452 | -0.742 | |
| Price To Operating Cash Flow Ratio | -33.077 | -26.616 | -15.157 | -6.457 | -0.751 | |
| Debt To Assets Ratio | 0.422 | 0.352 | 0.188 | 0.192 | 0.304 | |
| Debt To Equity Ratio | 1.267 | 0.885 | 0.336 | 0.371 | 0.551 | |
| Debt To Capital Ratio | 0.559 | 0.470 | 0.251 | 0.270 | 0.355 | |
| Long Term Debt To Capital Ratio | 0.553 | 0.465 | 0.230 | 0.000 | 0.000 | |
| Financial Leverage Ratio | 3.005 | 2.515 | 1.784 | 1.933 | 1.815 | |
| Working Capital Turnover Ratio | 1.423 | 1.407 | 0.877 | 0.618 | 0.082 | |
| Operating Cash Flow Ratio | -0.479 | -0.576 | -1.780 | -1.068 | -2.888 | |
| Operating Cash Flow Sales Ratio | -0.104 | -0.134 | -0.721 | -1.343 | -15.109 | |
| Free Cash Flow Operating Cash Flow Ratio | 1.035 | 1.023 | 1.004 | 1.001 | 1.012 | |
| Debt Service Coverage Ratio | -1.009 | -0.845 | -6.299 | -1.919 | -4.103 | |
| Interest Coverage Ratio | -1.443 | -1.391 | -7.130 | -12.568 | -34.284 | |
| Short Term Operating Cash Flow Coverage Ratio | -28.724 | 0.000 | 0.000 | -2.622 | -4.728 | |
| Operating Cash Flow Coverage Ratio | -0.201 | -0.292 | -1.603 | -1.921 | -3.352 | |
| Capital Expenditure Coverage Ratio | -28.474 | -44.321 | -260.805 | -1,273.527 | -81.709 | |
| Dividend Paid And Capex Coverage Ratio | -28.474 | -44.321 | -260.805 | -1,273.527 | -81.709 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | -53.091 | -76.655 | -25.190 | -6.438 | -0.581 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 89.5% | ▲4.7% | ▲1.1% |
| Ebit Margin | -7.9% | ▼-2.3% | ▲332.1% |
| Ebitda Margin | -7.2% | ▼-2.1% | ▲326.4% |
| Operating Profit Margin | -10.1% | ▼-1.7% | ▲334.0% |
| Pretax Profit Margin | -14.9% | ▼-3.2% | ▲340.0% |
| Continuous Operations Profit Margin | -15.1% | ▼-3.4% | ▲339.9% |
| Net Profit Margin | -15.1% | ▼-3.4% | ▲339.9% |
| Bottom Line Profit Margin | -15.1% | ▼-3.4% | ▲339.9% |
| Current Ratio | 4.315 | ▼-0.265 | ▲0.585 |
| Quick Ratio | 4.115 | ▼-0.193 | ▲0.538 |
| Solvency Ratio | -0.175 | ▼-0.034 | ▲0.593 |
| Cash Ratio | 0.767 | ▼-0.067 | ▼-0.205 |
| Price To Earnings Ratio | -22.423 | ▲7.401 | ▼-6.338 |
| Price To Earnings Growth Ratio | -0.423 | ▼-1.112 | ▼-0.637 |
| Forward Price To Earnings Growth Ratio | -0.423 | ▼-1.112 | ▼-0.637 |
| Price To Earnings Diluted Ratio | -22.423 | ▲7.401 | ▼-6.338 |
| Price To Earnings Diluted Growth Ratio | -0.423 | ▼-1.112 | ▼-0.637 |
| Price To Book Ratio | 8.417 | ▲1.535 | ▲2.530 |
| Price To Sales Ratio | 3.450 | ▼-0.125 | ▼-4.145 |
| Price To Free Cash Flow Ratio | -31.955 | ▼-5.926 | ▼-15.900 |
| Price To Operating Cash Flow Ratio | -33.077 | ▼-6.462 | ▼-16.666 |
| Debt To Assets Ratio | 0.422 | ▲0.070 | ▲0.130 |
| Debt To Equity Ratio | 1.267 | ▲0.382 | ▲0.585 |
| Debt To Capital Ratio | 0.559 | ▲0.089 | ▲0.178 |
| Long Term Debt To Capital Ratio | 0.553 | ▲0.087 | ▲0.303 |
| Financial Leverage Ratio | 3.005 | ▲0.490 | ▲0.794 |
| Working Capital Turnover Ratio | 1.423 | ▲0.017 | ▲0.542 |
| Operating Cash Flow Ratio | -0.479 | ▲0.096 | ▲0.879 |
| Operating Cash Flow Sales Ratio | -0.104 | ▲0.030 | ▲3.378 |
| Free Cash Flow Operating Cash Flow Ratio | 1.035 | ▲0.013 | ▲0.020 |
| Debt Service Coverage Ratio | -1.009 | ▼-0.164 | ▲1.826 |
| Interest Coverage Ratio | -1.443 | ▼-0.052 | ▲9.920 |
| Short Term Operating Cash Flow Coverage Ratio | -28.724 | ▼-28.724 | ▼-21.509 |
| Operating Cash Flow Coverage Ratio | -0.201 | ▲0.091 | ▲1.273 |
| Capital Expenditure Coverage Ratio | -28.474 | ▲15.848 | ▲309.293 |
| Dividend Paid And Capex Coverage Ratio | -28.474 | ▲15.848 | ▲309.293 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | -53.091 | ▲23.564 | ▼-20.700 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $1.41B | $1.19B | $1.36B | $452.3M | $114.6M | |
| Enterprise value | $1.55B | $1.28B | $1.39B | $392.6M | $87.7M | |
| EV / Sales | 3.80x | 3.84x | 11.20x | 7.53x | 8.69x | |
| EV / Op. cash flow | -36.46x | -28.59x | -15.54x | -5.61x | -0.57x | |
| EV / Free cash flow | -35.22x | -27.96x | -15.48x | -5.60x | -0.57x | |
| EV / EBITDA | -53.09x | -76.66x | -25.19x | -6.44x | -0.58x | |
| Net debt / EBITDA | -4.92x | -5.30x | -0.62x | 0.98x | 0.18x | |
| Current ratio | 4.32x | 4.58x | 4.88x | 2.34x | 2.53x | |
| Income quality | 0.69x | 1.15x | 1.36x | 1.04x | 0.96x | |
| Graham net-net | -$0 | $0 | $0 | $0 | $0 | |
| Tax burden | 101.6% | 100.7% | 100.8% | 100.0% | 100.0% | |
| Interest burden | 188.1% | 207.0% | 115.7% | 108.2% | 102.9% | |
| Working capital | $293.7M | $278.6M | $195.7M | $88.0M | $80.8M | |
| Invested capital | $300.7M | $282.5M | $202.3M | $98.5M | $95.9M | |
| Return on assets | -12.3% | -9.0% | -22.2% | -35.4% | -105.5% | |
| Operating ROA | -8.7% | -7.6% | -26.0% | -37.5% | -87.8% | |
| Return on tangible assets | -12.3% | -9.0% | -22.2% | -35.4% | -105.5% | |
| Return on equity | -36.9% | -22.6% | -39.6% | -68.3% | -191.4% | |
| Return on invested capital | -9.9% | -7.8% | -25.1% | -41.1% | -116.2% | |
| Return on capital employed | -9.9% | -7.8% | -25.6% | -51.2% | -159.0% | |
| Earnings yield | -4.4% | -3.3% | -4.9% | -14.9% | -138.0% | |
| Free cash flow yield | -3.1% | -3.8% | -6.6% | -15.5% | -134.7% | |
| Capex / Op. cash flow | -3.5% | -2.3% | -0.4% | -0.1% | -1.2% | |
| Capex / Depreciation | 48.8% | 49.0% | 26.6% | 4.8% | 129.6% | |
| Capex / Sales | 0.4% | 0.3% | 0.3% | 0.1% | 18.5% | |
| SG&A / Sales | 82.8% | 77.5% | 108.0% | 146.9% | 716.1% | |
| R&D / Sales | 16.8% | 15.7% | 28.6% | 67.5% | 902.6% | |
| Stock comp / Sales | 12.0% | 11.2% | 10.9% | 20.6% | 119.2% | |
| Intangibles / Total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Days sales outstanding | 64d | 63d | 65d | 54d | 18d | |
| Days payables outstanding | 165d | 116d | 228d | 963d | 1561d | |
| Operating cycle | 216d | 216d | 320d | 345d | 18d | |
| Cash conversion cycle | 52d | 100d | 91d | -618d | -1543d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+17.8%EV / Sales ▼-1.0%EV / EBITDA ▲+30.7%EV / Op. cash flow ▼-7.866Earnings yield ▼-0.011
Profitability
Return on equity ▼-0.143Return on assets ▼-0.033Return on invested capital ▼-0.021Return on capital employed ▼-0.021Operating ROA ▼-0.011Income quality ▼-0.455Tax burden ▲+0.009
Efficiency
Days sales outstanding ▲+1.249Days payables outstanding ▲+49.307Operating cycle ▲+0.355Cash conversion cycle ▼-48.951Capex / Sales ▲+0.001R&D / Sales ▲+0.011
Balance-sheet strength
Current ratio ▼-0.265Net debt / EBITDA ▲+0.373Working capital ▲+15090000.000Invested capital ▲+18194000.000Intangibles / Total assets n/a
Change over 5 years
Valuation
Market cap ▲+1125.9%EV / Sales ▼-56.2%EV / EBITDA ▼-9031.9%EV / Op. cash flow ▼-35.883Earnings yield ▲+1.336
Profitability
Return on equity ▲+1.545Return on assets ▲+0.932Return on invested capital ▲+1.063Return on capital employed ▲+1.490Operating ROA ▲+0.791Income quality ▼-0.275Tax burden ▲+0.016
Efficiency
Days sales outstanding ▲+46.236Days payables outstanding ▼-1396.283Operating cycle ▲+198.205Cash conversion cycle ▲+1594.488Capex / Sales ▼-0.181R&D / Sales ▼-8.858
Balance-sheet strength
Current ratio ▲+1.785Net debt / EBITDA ▼-5.101Working capital ▲+212884000.000Invested capital ▲+204749000.000Intangibles / Total assets n/a
Employee count
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-08-18 Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Ardelyx (ARDX) Ardelyx shares fell nearly 18% on August 7, 2026 after the Company cut its full-year IBSRELA revenue guidance -- a range it had reiterated just over three months earlier. Levi & Korsinsky is investigating potential securities law violations Ardelyx shares fell nearly 18% on August 7, 2026 after the Company cut its full-year IBSRELA revenue guidance -- a range it had reiterated just over three months earlier. Levi & Korsinsky is investigating potential securities law violations
- 2026-08-17 ARDX Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Ardelyx (ARDX) Every 100 shares of Ardelyx (NASDAQ: ARDX) held into August 7, 2026 lost about $87 in value as the stock fell 17.86% to close at $4.00 following the Company''s s
- 2026-08-17 ARDX Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Ardelyx (ARDX) NEW YORK--(BUSINESS WIRE)--Every 100 shares of Ardelyx (NASDAQ: ARDX) held into August 7, 2026 lost about $87 in value as the stock fell 17.86% to close at $4.00 following the Company''s second quarter report. If you held ARDX shares and lost money, you are encouraged to submit your loss information for review. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. The damage came alongside numbers the Company itself called records. Arde.
- 2026-08-14 ARDX SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Ardelyx /PRNewswire/ -- Payer coverage restrictions allegedly cost Ardelyx (NASDAQ: ARDX) shareholders roughly 18% of their investment on August 7, 2026, when the
- 2026-08-13 Ardelyx Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Ardelyx (ARDX) Ardelyx Investigation Notice: Levi and Korsinsky Notifies Investors of Pending Investigation Into Ardelyx (ARDX) PR Newswire
- 2026-08-13 Ardelyx Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Ardelyx (ARDX) ARDX closed at $4.00 on August 7, 2026 -- down 17.86% -- after Q2 product revenue of $118.1 million came in below consensus and analysts cut price targets in accord. NEW YORK, Aug. 13, 2026 /PRNewswire/ -- Ardelyx (NASDAQ: ARDX) shares closed at $4.00 on August 7, 2026, an 17.86% single-session decline, after the Company reported second quarter 2026 product revenue of $118.1 million and a loss of approximately $(0.07) per share -- both below consensus estimates.
- 2026-08-12 Ardelyx Q2: Strong Demand, But Payer Friction Clouds The Story Ardelyx, Inc. remains a hold due to near-term execution uncertainty despite strong underlying demand for IBSRELA and a robust long-term opportunity. ARDX''s Q2 revenue grew 31% YoY, driven by IBSRELA and XPHOZAH, but payer friction is capping near-term monetization and led to a guidance cut. Management is actively addressing access bottlenecks with expanded reimbursement teams, pharmacy network optimization, and increased sales force to convert demand into realized revenue.
- 2026-08-07 Ardelyx, Inc. (ARDX) Q2 2026 Earnings Call Transcript Ardelyx, Inc. (ARDX) Q2 2026 Earnings Call Transcript
- 2026-08-07 New Strong Sell Stocks for August 7th ARDX, ARDT and GPRE have been added to the Zacks Rank #5 (Strong Sell) List on August 7th, 2026.
- 2026-08-06 Compared to Estimates, Ardelyx (ARDX) Q2 Earnings: A Look at Key Metrics While the top- and bottom-line numbers for Ardelyx (ARDX) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.